Literature DB >> 12760823

Urban Tuberculosis: The New Face of an Old Problem.

Jennifer A. LaRosa1, Michael Cutaia.   

Abstract

Tuberculosis (TB) persists as a worldwide health crisis. Nearly one third of the world's population is infected with TB and it remains a critical public health issue. In the past two decades, international efforts have focused on improving identification of those infected with TB as well as supporting molecular microbiologists in developing better diagnostic techniques. Furthermore, implementation of programs such as directly observed therapy have assisted more patients in receiving and completing therapy. This review aims to identify some of the more relevant findings in the field of TB over the past few years with a special emphasis on TB in urban communities.

Entities:  

Year:  2003        PMID: 12760823     DOI: 10.1007/s11908-003-0080-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  35 in total

Review 1.  Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

2.  Temporal trends in tuberculosis hospitalization rates before and after implementation of directly observed therapy: New York City, 1988-1995.

Authors:  Mary Beth Terry; Moïse Desvarieux; Margaret Short
Journal:  Infect Control Hosp Epidemiol       Date:  2002-04       Impact factor: 3.254

Review 3.  Prevention of tuberculosis. Vigilance and infection control strategies are mainstays of efforts.

Authors:  M Means-Markwell; K M O'Neil
Journal:  Postgrad Med       Date:  2000-08       Impact factor: 3.840

Review 4.  Management of tuberculosis. Choosing an effective regimen and ensuring compliance.

Authors:  A Lazarus; J Sanders
Journal:  Postgrad Med       Date:  2000-08       Impact factor: 3.840

5.  Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

Authors:  M Narita; D Ashkin; E S Hollender; A E Pitchenik
Journal:  Am J Respir Crit Care Med       Date:  1998-07       Impact factor: 21.405

6.  Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.

Authors:  F Gordin; R E Chaisson; J P Matts; C Miller; M de Lourdes Garcia; R Hafner; J L Valdespino; J Coberly; M Schechter; A J Klukowicz; M A Barry; R J O'Brien
Journal:  JAMA       Date:  2000-03-15       Impact factor: 56.272

7.  Changes in the transmission of tuberculosis in New York City from 1990 to 1999.

Authors:  Elvin Geng; Barry Kreiswirth; Cynthia Driver; Jiehui Li; Joseph Burzynski; Phyllis DellaLatta; Angel LaPaz; Neil W Schluger
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

8.  Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-08-31       Impact factor: 17.586

Review 9.  Thoracic sequelae and complications of tuberculosis.

Authors:  H Y Kim; K S Song; J M Goo; J S Lee; K S Lee; T H Lim
Journal:  Radiographics       Date:  2001 Jul-Aug       Impact factor: 5.333

10.  Should bronchoscopy be performed in the evaluation of suspected pediatric pulmonary tuberculosis?

Authors:  Haim Bibi; Albert Mosheyev; David Shoseyov; David Feigenbaum; Edna Kurzbart; Zeev Weiller
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.